Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading neurological and cardiometabolic franchises. To learn more, visit www.ionispharma.com.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
Yes